Evaluation of pharmacists' interventions at a university teaching hospital

Canadian Journal of Hospital Pharmacy

Volumn 58, Issue 1, 2005, Pages 20-25

  Olson, Lynda M ^a,b   Desai, Sheetal ^c   Soto, Marisa L ^d   Namazifard, Shaida ^e   Quelland, Amanda K ^e   Erstad, Brian L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b ADVOCATE CHRIST MEDICAL CENTER   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d El Rio Disease State Mgmt Program   (United States)

^e UNIVERSITY OF ARIZONA MEDICAL CENTER   (United States)

Author keywords

Cost benefit analysis; Interventions; Medication errors

Indexed keywords

ARTICLE; CLINICAL PHARMACY; COST BENEFIT ANALYSIS; COST CONTROL; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG INFORMATION; DRUG OVERDOSE; DRUG SAFETY; ECONOMIC EVALUATION; HEALTH ECONOMICS; HOSPITAL PERSONNEL; HOSPITAL PHARMACY; HUMAN; INFORMATION PROCESSING; MEDICAL DOCUMENTATION; PATIENT CARE; PHARMACEUTICAL CARE; PILOT STUDY; RETROSPECTIVE STUDY; TEACHING HOSPITAL; TREATMENT PLANNING; UNIVERSITY HOSPITAL;

EID: 14944386077     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Smith SR, Utterback CM, Parr DD, Waller DJ. Pharmacist clinical intervention program. Top Hosp Pharm Manage 1993;13(2):1-15.
2. American Society of Health-System Pharmacists. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Health Syst Pharm 1995;52:417-9.
3. American Society of Hospital Pharmacists. ASHP guidelines on preventing medication errors in hospitals. Am J Hosp Pharm 1993;50:305-14.
4. Manasse HR Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 1. Am J Hosp Pharm 1989;46:929-44.
5. Kohn LT, Corrigan JM, Donaldson M, editors. To err is human: building a safer health system. Washington (DC): Institute of Medicine; 1999.
6. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med 1995;155:1949-56.
7. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. JAMA 1997;277:307-11.
8. Mutnick AH, Sterba KJ, Peroutka JA, Sloan NE, Belz EA, Sorenson MK, et al. Cost savings and avoidance from clinical interventions. Am J Health Syst Pharm 1997;54:392-6.
9. Weidle P, Bradley L, Gallina J, Mullins CD, Thorn D, Siegel LP. Pharmaceutical care intervention documentation program and related cost savings at a university hospital. Hosp Pharm 1999;34:43-52.
10. Taylor CT, Church CO, Byrd DC. Documentation of clinical interventions by pharmacy faculty, residents, and students. Ann Pharmacother 2000;34:843-7.
11. Taylor, JT, Kathman SM. Documentation of cost savings from decentralized clinical pharmacy services at a community hospital. Am J Hosp Pharm 1991;48:1467-70.
12. Janning SW, Stevenson JG, Smolarek RT. Implementing comprehensive pharmaceutical services at an academic tertiary care hospital. Am J Health Syst Pharm 1996;53:542-7.
13. Bjornson DC, Hiner WO, Potyk RP, Nelson BA, Lombardo FA, Morton TA, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 1993;50:1875-84.
14. Gandhi PJ, Smith BS, Tataronis GR, Maas B. Impact of a pharmacist on drug cost in a coronary care unit. Am J Health Syst Pharm 2001;58:497-503.
15. Nesbit TW, Shermock KM, Bobek MB, Capozzi DL, Flores PA, Leonard MC, et al. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model. Am J Health Syst Pharm 2001;58:784-90.
16. Leape LL, Cullen DJ, Dempsey-Clapp M, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
17. Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy 1999;19:556-64.
18. Overhage JM, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists' clinical activities. Am J Health Syst Pharm 1999;56:2444-50.
19. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. JAMA 1995;274:29-34.